Solid Biosciences Valuation
| SLDB Stock | USD 5.69 0.09 1.56% |
At this time, the company appears to be undervalued. Solid Biosciences LLC has a current Real Value of $5.94 per share. The regular price of the company is $5.69. Our model measures the value of Solid Biosciences LLC from inspecting the company fundamentals such as Return On Equity of -0.66, shares owned by institutions of 90.06 %, and Shares Outstanding of 39.95 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Solid Biosciences' valuation include:
Price Book 1.3611 | Enterprise Value 80.9 M | Enterprise Value Ebitda (3.69) | Price Sales 3.6454 | Enterprise Value Revenue 1.1559 |
Undervalued
Today
Please note that Solid Biosciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Solid Biosciences LLC is based on 3 months time horizon. Increasing Solid Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Solid Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Solid Stock. However, Solid Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.69 | Real 5.94 | Target 6.75 | Hype 5.34 | Naive 5.82 |
The real value of Solid Stock, also known as its intrinsic value, is the underlying worth of Solid Biosciences LLC Company, which is reflected in its stock price. It is based on Solid Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Solid Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Solid Biosciences LLC helps investors to forecast how Solid stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Solid Biosciences more accurately as focusing exclusively on Solid Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Solid Biosciences' intrinsic value based on its ongoing forecasts of Solid Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Solid Biosciences' closest peers. If more than one evaluation category is relevant for Solid Biosciences we suggest using both methods to arrive at a better estimate.
Solid Biosciences Cash |
|
Solid Valuation Trend
Comparing Solid Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Solid Biosciences LLC uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Solid Biosciences Total Value Analysis
Solid Biosciences LLC is at this time forecasted to have valuation of 80.94 M with market capitalization of 227.34 M, debt of 26.27 M, and cash on hands of 162.88 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Solid Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
80.94 M | 227.34 M | 26.27 M | 162.88 M |
Solid Biosciences Asset Utilization
One of the ways to look at asset utilization of Solid is to check how much profit was generated for every dollar of assets it reports. Solid Biosciences LLC has a negative utilization of assets of -0.35 %, losing $0.003533 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Solid Biosciences LLC shows how discouraging it operates for each dollar spent on its assets.Solid Biosciences Ownership Allocation
Solid Biosciences LLC shows a total of 39.95 Million outstanding shares. The majority of Solid Biosciences LLC outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Solid Biosciences to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Solid Biosciences LLC. Please pay attention to any change in the institutional holdings of Solid Biosciences LLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Solid Biosciences Profitability Analysis
Net Loss for the year was (96.02 M) with profit before overhead, payroll, taxes, and interest of 13.62 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Solid Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Solid Biosciences and how it compares across the competition.
About Solid Biosciences Valuation
The stock valuation mechanism determines Solid Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Solid Biosciences. We calculate exposure to Solid Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Solid Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -76.6 M | -72.7 M | |
| Pretax Profit Margin | (12.22) | (12.83) | |
| Operating Profit Margin | (15.12) | (15.88) | |
| Net Loss | (9.31) | (9.77) | |
| Gross Profit Margin | 0.63 | 0.66 |
Solid Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 19.9 M |
Solid Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Solid Biosciences LLC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Solid we look at many different elements of the entity such as Solid's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Solid Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Solid Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Solid Biosciences' worth.Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |